Tag:
GNS Healthcare
Latest Headlines
Latest Headlines
Check the pulse of biotech IT in Boston
Biotech computing folks from around the world descended on Boston this week, and the FierceBiotech IT team was among them.
Check the pulse of biotech IT in Boston
Biotech computing folks from around the world descended on Boston this week, and the FierceBiotech IT team was among them. Check out the slide show.
J&J hires Selventa to build computerized models for personalized medicine
Selventa has embarked on a multiyear project to furnish healthcare giant Johnson & Johnson's ( $JNJ ) Janssen R&D group with disease models, in an effort to understand the mechanisms of...
GNS Healthcare CEO launches Forbes blog
Colin Hill has a new platform from which to speak out on "big data" analytics in healthcare and other hot topics. The CEO of GNS Healthcare, who should be known to many FierceBiotechIT ...
Supercomputers combat bad drug events for Boston hospital
A new front is opening up in the ongoing effort to identify bad drug reactions, a major sore spot for drug companies and healthcare providers. Harvard doctors are using supercomputing technology to
BMS taps GNS Heathcare for computer model of inflammation
GNS Healthcare has bagged a deal with a major pharma. Bristol-Myers Squibb ($BMY) is working with the health analytics firm on a new computer model of immuno-inflammation, according to GNS. And the
NCI taps start-up GNS's supercomputing tech for lung cancer analysis
The National Cancer Institute (NCI) wants to employ some supercomputers to help its researchers conquer lung cancer--the cancer causing the most deaths among Americans. GNS Healthcare, a provider of
Supercomputing poised for leading R&D role in personalized medicine
Humans just aren't smart enough to realize the full potential of personalized medicine alone. And while modern sequencing platforms yield huge amounts of molecular data to advance studies,
AstraZeneca plans tech center in Russia, aims to use informatics to predict drug safety
AstraZeneca wants to invest in advanced software to help predict the safety and efficacy of drugs. The London-based drugmaker ($AZN) plans to open a "Predictive Science Centre" in St. Petersburg,
